CAI vs SNOW · rev $812.0M vs rev $1.55B
Caris Life Sciences, Inc. Common Stock (CAI) versus Snowflake Inc. (SNOW) — a side-by-side from cached financials, not a winner call.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
Snowflake Inc. (SNOW) is a software - application company listed on US. It is led by Sridhar Ramaswamy.
Latest reported CAI revenue for 2025-12-31 was $812.0M. Net income was -$68.1M. Revenue was up 97.0% from 2024-12-31 to 2025-12-31. CAI currently screens at market cap $5.22B.
Latest reported SNOW revenue for 2026-07-31 was $1.55B. Net income was -$191.7M. Revenue was up 11.2% from 2026-04-30 to 2026-07-31. SNOW currently screens at market cap $73.90B.
CAI currently screens at market cap $5.22B. SNOW currently screens at market cap $73.90B.
Not investment advice. Open the CAI and SNOW stock pages for the full models.
Not investment advice.